1.
Buti S, Donini M, Lazzarelli, et al. S. A new modified schedule of Sunitinib for metastatic renal cell carcinoma: a retrospective analysis. Acta Biomed [Internet]. 2012 Oct. 1 [cited 2026 Apr. 30];83(2):88-94. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/2367